.png)
.png)
.png)
.png)
The 2027 Cholestatic Liver Disease Summit brings together multiple liver disease communities for a dynamic four-day event, including a two-day Scientific Meeting, Research Roundtable Meeting, and Community Conference.
​
Bringing together stakeholders from Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis, and Biliary Atresia—along with representation from Primary Sclerosing Cholangitis and other cholestatic liver disease communities—the Summit creates a unique opportunity to bridge knowledge gaps, foster scientific collaboration, strengthen patient and family connections, and inspire hope for the future of cholestatic liver disease care. We are Stepping Up to the Plate for Cholestatic Liver Disease!​
​
Registration for the CLD All Stars Cholestatic Liver Disease Summit will open soon!
​
In the meantime, please read about the inaugural 2025 Cholestatic Liver Disease Summit below.
​
The 2025 CLD Summit was held in Aurora, Colorado at the Hyatt Regency Aurora-Denver Conference Center in partnership with Children’s Hospital Colorado. The Summit built on the institution’s extensive history in the research and treatment of Alagille Syndrome, PFIC, BA, PSC, and other cholestatic liver diseaseses.
​​By bringing together these communities, the Summit advanced both individual disease understanding and cross-disease collaboration—highlighting shared challenges and opportunities to improve outcomes across the cholestatic liver disease spectrum.
​
One of the key outcomes of the Summit was the development of the Findings from the 2025 Cholestatic Liver Disease Summit Research Roundtable Meetings White Paper, which captures participant-reported insights and identifies priorities for future research, care, and collaboration.
👉 The full White Paper is available for download in the callout box on this page.
​
We are grateful to the scientists, researchers, clinicians, industry partners, patients, and families who participated and contributed to the success of this inaugural event.
​
Together, we continue to hold High Hopes for Cholestatic Liver Disease families.
​
We hope you will join us in 2027!
.png)
Alagille Syndrome Alliance
The Alagille Syndrome Alliance (ALGSA) is the leading 501c3 patient advocacy organization in the world serving families affected by Alagille Syndrome, a rare cholestatic liver disease and one of over 7,000 rare diseases in the world.
​
PFIC Advocacy & Resource Network, Inc.
PFIC Network was founded by PFIC families & providing direct support and disease education to patients is at the heart of our organization.
​
BARE, Inc.
BARE was created to help solve some of the deficiencies and frustrations that currently exist in the Biliary Atresia community. We believe creating an organization dedicated solely to Biliary Atresia, will help push for progress in finding a cause, treatment, and one day, a cure.
​
Children’s Mercy Kansas City
Children’s Mercy Kansas City is a top-ranked, independent pediatric academic medical center founded in 1897, providing comprehensive care to patients from birth to age 21. It is nationally recognized by U.S. News & World Report in multiple specialties and holds consecutive Magnet® designations for nursing excellence.
.png){kind=small}
